Showing results (391-400 of 434) with videos related to
Sort By:
Pageof 44
Human Reproduction (Oxford, England)|June 1, 1995
The Euro-Team Early Pregnancy (ETEP) protocol for recurrent miscarriageC W Berry, B Brambati, T K Eskes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III studyVolker Moebus, Christian Jackisch, Hans-Joachim Lueck, et al.Tumour Virus Research|July 27, 2023
Association of two genomic variants with HPV type-specific risk of cervical cancerFinja Seifert, Rieke Eisenblätter, Julia Beckmann, et al.International Journal of Surgery (London, England)|February 24, 2025
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysisFabian Trillsch, Bastian Czogalla, Sven Mahner, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup StudyJ Sehouli, I B Runnebaum, C Fotopoulou, et al.JCO Precision Oncology|January 30, 2023
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 TrialEric Pujade-Lauraine, Jessica Brown, Alan Barnicle, et al.Water Research|July 6, 2020
Field test of electrokinetically-delivered thermally activated persulfate for remediation of chlorinated solvents in clayNicholas A Head, Jason I Gerhard, Ainsley M Inglis, et al.Gynecologic Oncology|December 10, 2024
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trialMansoor R Mirza, Line Bjørge, Frederik Marmé, et al.Pharmacogenetics|October 23, 2001
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptivesI B Runnebaum, S Wang-Gohrke, D Vesprini, et al.The Lancet. Oncology|June 12, 2010
Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational studyMaaike H Oonk, Bettien M van Hemel, Harry Hollema, et al.Pageof 44